PATENT CLAIM ANALYSIS

Application Number: 16258606
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "374000"]

Abstract:
The present invention is directed to methods of treating and/or ameliorating portal hypertension by administration of a therapeutically effective amount of ifetroban or a pharmaceutically acceptable salt thereof.

Claim (Index 20):
The method of  claim 1 , wherein the mammal is a human patient with portal hypertension and the therapeutically effective amount of the thromboxane A 2  receptor antagonist or a pharmaceutically acceptable salt thereof allows for short and/or long-term relief of portal hypertension and cirrhosis through reduction in vasoconstriction and fibrosis.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 99.0
- Lexical Diversity: 1.11538
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14715143', '15592727', '16240368', '15608507', '16004666']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8131539896636013
- 35 USC 102 Novelty (BERT): 0.5835528638300091
- Combined Prediction Score: 0.7901938770802421
- Mean Citation Score: 481.51012
- Max Citation Score: 512.1572
- Similarity Product: 383.2664423670769

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test